Login Register Cart 0
Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Nutritional and Herbal Supplements for Weight Loss Management: A Review

Author(s): Ajay R. Nannar*, Raosaheb S. Shendge and Kishor S. Salunkhe

Volume 20, Issue 5, 2024

Published on: 18 August, 2023

Page: [636 - 645] Pages: 10

DOI: 10.2174/1573401319666230725105537

Price: $65

Abstract

Millions of dollars have been spent on nutritional and herbal supplements, which are used by many overweight people to lose weight. However, there are concerns about the effectiveness and safety of several supplements. By boosting energy expenditure, satiety, fat oxidation, inhibiting dietary fat absorption, moderating carbohydrate metabolism, raising fat excretion, increasing water elimination, and improving mood, supplements are thought to aid in weight reduction. This study provides an overview of the present status of the research on a few particular dietary supplements, herbal combinations, and combination products, as this field is evolving quickly. More studies on numerous supplements are required to verify their efficacy because they have not been examined in randomised controlled trials. Nutritionists and medical experts should go through dietary supplement use with patients and notify the FDA of any negative side effects. Additional rules would be required for the manufacture, sale, and marketing of these supplements.

Keywords: Dietary supplements, herbal supplements, carbohydrate metabolism, efficacy, weight loss, FDA.

« Previous Next »
Graphical Abstract

[1]
Landsberg L, Aronne LJ, Beilin LJ, et al. Obesity-related hypertension: Pathogenesis, cardiovascular risk, and treatment-a position paper of the the obesity society and the American society of hypertension. Obesity 2013; 21(1): 8-24.
[http://dx.doi.org/10.1002/oby.20181] [PMID: 23401272]
[2]
Arroyo-Johnson C, Mincey KD. Obesity epidemiology worldwide. Gastroenterol Clin North Am 2016; 45(4): 571-9.
[http://dx.doi.org/10.1016/j.gtc.2016.07.012] [PMID: 27837773]
[3]
Lefèbvre P, Scheen A. Obesity: Causes and new treatments. Exp Clin Endocrinol Diabetes 2001; 109(2): S215-24.
[http://dx.doi.org/10.1055/s-2001-18583] [PMID: 11460572]
[4]
Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: An endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2015; 100(2): 342-62.
[http://dx.doi.org/10.1210/jc.2014-3415] [PMID: 25590212]
[5]
Dietrich MO, Horvath TL. Limitations in anti-obesity drug development: The critical role of hunger-promoting neurons. Nat Rev Drug Discov 2012; 11(9): 675-91.
[http://dx.doi.org/10.1038/nrd3739] [PMID: 22858652]
[6]
Mead E, Atkinson G, Richter B, et al. Drug interventions for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev 2016; 11(11): CD012436.
[PMID: 27899001]
[7]
van der Schoor C, Oberholzer HM, Bester MJ, van Rooy MJ. The effect of sibutramine, a serotonin-norepinephrine reuptake inhibitor, on platelets and fibrin networks of male Sprague-Dawley rats: A descriptive study. Ultrastruct Pathol 2014; 38(6): 399-405.
[http://dx.doi.org/10.3109/01913123.2014.946635] [PMID: 25191960]
[8]
Kim JJ, Tarnoff ME, Shikora SA. Surgical treatment for extreme obesity: Evolution of a rapidly growing field. Nutr Clin Pract 2003; 18(2): 109-23.
[http://dx.doi.org/10.1177/0115426503018002109] [PMID: 16215028]
[9]
Ikramuddin S, Korner J, Lee WJ, et al. Durability of addition of Roux-en-Y Gastric Bypass to lifestyle intervention and medical management in achieving primary treatment goals for uncontrolled type 2 diabetes in mild to moderate obesity: A randomized control trial. Diabetes Care 2016; 39(9): 1510-8.
[http://dx.doi.org/10.2337/dc15-2481] [PMID: 27311493]
[10]
Park JY, Kim YJ. Laparoscopic Roux-en-Y gastric bypass in obese Korean patients: Efficacy and potential adverse events. Surg Today 2016; 46(3): 348-55.
[http://dx.doi.org/10.1007/s00595-015-1170-y] [PMID: 25913478]
[11]
Lambert J E, Parnell J A, Tunnicliffe J M, Han J, Sturzenegger T, Reimer R A. Consuming yellow pea fiber reduces voluntary energy intake and body fat in overweight/obese adults in a 12-week randomized controlled trial. Clin Nutr 2015; 36(1): 126-33.
[http://dx.doi.org/10.1016/j.clnu.2015.12.016] [PMID: 26811130]
[12]
Azushima K, Tamura K, Haku S, et al. Effects of the oriental herbal medicine Bofu-tsusho-san in obesity hypertension: A multicenter, randomized, parallel-group controlled trial (ATH-D-14-01021.R2). Atherosclerosis 2015; 240(1): 297-304.
[http://dx.doi.org/10.1016/j.atherosclerosis.2015.01.025] [PMID: 25818388]
[13]
Zhou Q, Chang B, Chen XY, et al. Chinese herbal medicine for obesity: A randomized, double-blinded, multicenter, prospective trial. Am J Chin Med 2014; 42(6): 1345-56.
[http://dx.doi.org/10.1142/S0192415X14500840] [PMID: 25406653]
[14]
Lenon GB, Li KX, Chang YH, et al. Efficacy and safety of a Chinese herbal medicine formula (RCM-104) in the management of simple obesity: A randomized, placebo-controlled clinical trial. Evid Based Complement Alternat Med 2012; 2012: 435702.
[http://dx.doi.org/10.1155/2012/435702] [PMID: 22550541]
[15]
Ke B, Shi L, Zhang J, Chen D, Meng J, Qin J. Protective effects of modified linggui zhugan decoction combined with short-term very low calorie diets on cardiovascular risk factors in obese patients with impaired glucose tolerance. J Tradit Chin Med 2012; 32(2): 193-8.
[http://dx.doi.org/10.1016/S0254-6272(13)60010-2] [PMID: 22876442]
[16]
Chu S-L, Fu H, Yang J-X, et al. A randomized double-blind placebo-controlled study of Pu’er tea extract on the regulation of metabolic syndrome. Chin J Integr Med 2011; 17(7): 492-8.
[http://dx.doi.org/10.1007/s11655-011-0781-4] [PMID: 21725873]
[17]
Li Z, Song R, Nguyen C, et al. Pistachio nuts reduce triglycerides and body weight by comparison to refined carbohydrate snack in obese subjects on a 12-week weight loss program. J Am Coll Nutr 2010; 29(3): 198-203.
[http://dx.doi.org/10.1080/07315724.2010.10719834] [PMID: 20833992]
[18]
Abidov M, Ramazanov Z, Seifulla R, Grachev S. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. Diabetes Obes Metab 2010; 12(1): 72-81.
[http://dx.doi.org/10.1111/j.1463-1326.2009.01132.x] [PMID: 19840063]
[19]
Gout B, Bourges C, Paineau-Dubreuil S. Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr Res 2010; 30(5): 305-13.
[http://dx.doi.org/10.1016/j.nutres.2010.04.008] [PMID: 20579522]
[20]
Datau EA, Wardhana EE, Surachmanto EE, Pandelaki K, Langi JA. Fias. Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male. Acta Med Indones 2010; 42(3): 130-4.
[PMID: 20724766]
[21]
Di Pierro F, Menghi AB, Barreca A, Lucarelli M, Calandrelli A. Greenselect Phytosome as an adjunct to a low-calorie diet for treatment of obesity: A clinical trial. Altern Med Rev 2009; 14(2): 154-60.
[PMID: 19594224]
[22]
Wang H, Wen Y, Du Y, et al. Effects of catechin enriched green tea on body composition. Obesity 2010; 18(4): 773-9.
[http://dx.doi.org/10.1038/oby.2009.256] [PMID: 19680234]
[23]
He R, Chen L, Lin B, Matsui Y, Yao X, Kurihara H. Beneficial effects of oolong tea consumption on diet-induced overweight and obese subjects. Chin J Integr Med 2009; 15(1): 34-41.
[http://dx.doi.org/10.1007/s11655-009-0034-8] [PMID: 19271168]
[24]
Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CMF, Oben JE. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids Health Dis 2009; 8(1): 7.
[http://dx.doi.org/10.1186/1476-511X-8-7] [PMID: 19254366]
[25]
Oben JE, Ngondi JL, Momo CN, Agbor GA, Sobgui C. The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: A double-blind placebo-controlled study. Lipids Health Dis 2008; 7(1): 12.
[http://dx.doi.org/10.1186/1476-511X-7-12] [PMID: 18377661]
[26]
Bahmani M, Eftekhari Z, Saki K, et al. Obesity phytotherapy: Review of native herbs used in traditional medicine for obesity. J Evid Based Complement Altern Med 2016; 21(3): 228-34.
[27]
Gogte VM. Medicinal Plants, Part III in Ayurvedic Pharmacology and Therapeutic Uses of Medicinal Plants (Dravyagunavignyan). Mumbai, India: Bhartiya Vidya Bhavan 2002.
[28]
Misra Vaisya R. Bhavaprakasha Nigantu. Varanasi, India: Chaukamba Sanskrit Sansthan 2005.
[29]
Yun JW. Possible anti-obesity therapeutics from nature - A review. Phytochemistry 2010; 71(14-15): 1625-41.
[http://dx.doi.org/10.1016/j.phytochem.2010.07.011] [PMID: 20732701]
[30]
Saper RB, Eisenberg DM, Phillips RS. Common dietary supplements for weight loss. Am Fam Physician 2004; 70(9): 1731-8.
[PMID: 15554492]
[31]
Ioannides-Demos LL, Piccenna L, McNeil JJ. Pharmacotherapies for obesity: Past, current, and future therapies. J Obes 2011; 2011: 1-18.
[http://dx.doi.org/10.1155/2011/179674] [PMID: 21197148]
[32]
Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources: Unexplored potential. Drug Discov Today 2007; 12(19-20): 879-89.
[http://dx.doi.org/10.1016/j.drudis.2007.07.024] [PMID: 17933690]
[33]
Tsujita T, Takaichi H, Takaku T, Aoyama S, Hiraki J. Antiobesity action of ɛ-polylysine, a potent inhibitor of pancreatic lipase. J Lipid Res 2006; 47(8): 1852-8.
[http://dx.doi.org/10.1194/jlr.M600168-JLR200] [PMID: 16723640]
[34]
Han LK, Zheng YN, Yoshikawa M, Okuda H, Kimura Y. Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complement Altern Med 2005; 5(1): 9.
[http://dx.doi.org/10.1186/1472-6882-5-9] [PMID: 15811191]
[35]
Han LK, Kimura Y, Okuda H, Xu B-J, Zheng Y. Platycodi radix affects lipid metabolism in mice with high fat diet-induced obesity. J Nutr 2000; 130(11): 2760-4.
[http://dx.doi.org/10.1093/jn/130.11.2760] [PMID: 11053518]
[36]
Kishino E, Ito T, Fujita K, Kiuchi Y. A mixture of the Salacia reticulata (Kotala himbutu) aqueous extract and cyclodextrin reduces the accumulation of visceral fat mass in mice and rats with high-fat diet-induced obesity. J Nutr 2006; 136(2): 433-9.
[http://dx.doi.org/10.1093/jn/136.2.433] [PMID: 16424124]
[37]
Ono Y, Hattori E, Fukaya Y, Imai S, Ohizumi Y. Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. J Ethnopharmacol 2006; 106(2): 238-44.
[http://dx.doi.org/10.1016/j.jep.2005.12.036] [PMID: 16495025]
[38]
Kim HY, Kang MH. Screening of Korean medicinal plants for lipase inhibitory activity. Phytother Res 2005; 19(4): 359-61.
[http://dx.doi.org/10.1002/ptr.1592] [PMID: 16041737]
[39]
Moreno DA, Ilic N, Poulev A, Raskin I. Effects of Arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters. Life Sci 2006; 78(24): 2797-803.
[http://dx.doi.org/10.1016/j.lfs.2005.11.012] [PMID: 16337240]
[40]
Shimoda H, Seki E, Aitani M. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med 2006; 6(1): 9.
[http://dx.doi.org/10.1186/1472-6882-6-9] [PMID: 16545124]
[41]
Han L-K, Takaku T, Li J, Kimura Y, Okuda H. Anti-obesity action of oolong tea. Int J Obes 1999; 23(1): 98-105.
[http://dx.doi.org/10.1038/sj.ijo.0800766] [PMID: 10094584]
[42]
Nakai M, Fukui Y, Asami S, et al. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J Agric Food Chem 2005; 53(11): 4593-8.
[http://dx.doi.org/10.1021/jf047814+] [PMID: 15913331]
[43]
Thielecke F, Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome - A review. Phytochemistry 2009; 70(1): 11-24.
[http://dx.doi.org/10.1016/j.phytochem.2008.11.011] [PMID: 19147161]
[44]
Kim HK, Della-Fera M, Lin J, Baile CA. Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. J Nutr 2006; 136(12): 2965-9.
[http://dx.doi.org/10.1093/jn/136.12.2965] [PMID: 17116704]
[45]
Spiegelman BM, Hu E, Kim JB, Brun R. PPARγ and the control of adipogenesis. Biochimie 1997; 79(2-3): 111-2.
[http://dx.doi.org/10.1016/S0300-9084(97)81500-3] [PMID: 9209705]
[46]
Lombardo YB, Chicco AG. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J Nutr Biochem 2006; 17(1): 1-13.
[http://dx.doi.org/10.1016/j.jnutbio.2005.08.002] [PMID: 16214332]
[47]
Murase T, Nagasawa A, Suzuki J, Hase T, Tokimitsu I. Beneficial effects of tea catechins on diet-induced obesity: Stimulation of lipid catabolism in the liver. Int J Obes 2002; 26(11): 1459-64.
[http://dx.doi.org/10.1038/sj.ijo.0802141] [PMID: 12439647]
[48]
Kao YH, Hiipakka RA, Liao S. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 2000; 141(3): 980-7.
[http://dx.doi.org/10.1210/endo.141.3.7368] [PMID: 10698173]
[49]
Sayama K, Lin S, Zheng G, Oguni I. Effects of green tea on growth, food utilization and lipid metabolism in mice. In Vivo 2000; 14(4): 481-4.
[PMID: 10945161]
[50]
Chien PJ, Chen YC, Lu SC, Sheu F. Dietary flavonoids suppress adipogenesis in 3T3-L1 preadipocytes. J Food Drug Anal 2005; 13(2): 168-75.
[51]
Hargrave KM, Li C, Meyer BJ, et al. Adipose depletion and apoptosis induced by trans-10, cis-12 conjugated linoleic Acid in mice. Obes Res 2002; 10(12): 1284-90.
[http://dx.doi.org/10.1038/oby.2002.174] [PMID: 12490673]
[52]
Hwang JT, Park IJ, Shin JI, et al. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005; 338(2): 694-9.
[http://dx.doi.org/10.1016/j.bbrc.2005.09.195] [PMID: 16236247]
[53]
Hsu CL, Yen GC. Induction of cell apoptosis in 3T3-L1 pre-adipocytes by flavonoids is associated with their antioxidant activity. Mol Nutr Food Res 2006; 50(11): 1072-9.
[http://dx.doi.org/10.1002/mnfr.200600040] [PMID: 17039455]
[54]
Yang JY, Della-Fera MA, Hartzell DL, Nelson-Dooley C, Hausman DB, Baile CA. Esculetin induces apoptosis and inhibits adipogenesis in 3T3-L1 cells. Obesity 2006; 14(10): 1691-9.
[http://dx.doi.org/10.1038/oby.2006.194] [PMID: 17062797]
[55]
Yang JY, Della-Fera MA, Rayalam S, et al. Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci 2008; 82(19-20): 1032-9.
[http://dx.doi.org/10.1016/j.lfs.2008.03.003] [PMID: 18433793]
[56]
Picard F, Kurtev M, Chung N, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 2004; 429(6993): 771-6.
[http://dx.doi.org/10.1038/nature02583] [PMID: 15175761]
[57]
Rayalam S, Dellafera M, Baile C. Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem 2008; 19(11): 717-26.
[http://dx.doi.org/10.1016/j.jnutbio.2007.12.007] [PMID: 18495457]
[58]
Flatt JP. Differences in basal energy expenditure and obesity. Obesity 2007; 15(11): 2546-8.
[http://dx.doi.org/10.1038/oby.2007.304] [PMID: 18070743]
[59]
Redinger RN. Fat storage and the biology of energy expenditure. Transl Res 2009; 154(2): 52-60.
[http://dx.doi.org/10.1016/j.trsl.2009.05.003] [PMID: 19595436]
[60]
Cannon B, Nedergaard J. Brown adipose tissue: Function and physiological significance. Physiol Rev 2004; 84(1): 277-359.
[http://dx.doi.org/10.1152/physrev.00015.2003] [PMID: 14715917]

Rights & Permissions Print Cite
Article Metrics
16
3
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy